These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 33515508)

  • 21. Impact of rubella vaccination strategy on the occurrence of congenital rubella syndrome.
    Lanzieri TM; Pinto D; Prevots DR
    J Pediatr (Rio J); 2007; 83(5):415-21. PubMed ID: 17853958
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Burden of congenital rubella syndrome after a community-wide rubella outbreak, Rio Branco, Acre, Brazil, 2000 to 2001.
    Lanzieri TM; Segatto TC; Siqueira MM; de Oliviera Santos EC; Jin L; Prevots DR
    Pediatr Infect Dis J; 2003 Apr; 22(4):323-9. PubMed ID: 12690271
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The epidemiology of rubella in England and Wales before and after the 1994 measles and rubella vaccination campaign: fourth joint report from the PHLS and the National Congenital Rubella Surveillance Programme.
    Miller E; Waight P; Gay N; Ramsay M; Vurdien J; Morgan-Capner P; Hesketh L; Brown D; Tookey P; Peckham C
    Commun Dis Rep CDR Rev; 1997 Feb; 7(2):R26-32. PubMed ID: 9046126
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting rubella for elimination.
    Taneja DK; Sharma P
    Indian J Public Health; 2012; 56(4):269-72. PubMed ID: 23354136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Accelerated control of rubella and prevention of congenital rubella syndrome, Brazil.
    Wkly Epidemiol Rec; 2002 May; 77(21):169-75. PubMed ID: 12060965
    [No Abstract]   [Full Text] [Related]  

  • 26. Rubella surveillance to June 1994: third joint report from the PHLS and the National Congenital Rubella Surveillance Programme.
    Miller E; Tookey P; Morgan-Capner P; Hesketh L; Brown D; Waight P; Vurdien J; Jones G; Peckham C
    Commun Dis Rep CDR Rev; 1994 Nov; 4(12):R146-52. PubMed ID: 7529090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Congenital rubella syndrome: a matter of concern.
    Martínez-Quintana E; Castillo-Solórzano C; Torner N; Rodríguez-González F
    Rev Panam Salud Publica; 2015 Mar; 37(3):179-86. PubMed ID: 25988255
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progress Toward Rubella and Congenital Rubella Syndrome Control and Elimination - Worldwide, 2000-2018.
    Grant GB; Desai S; Dumolard L; Kretsinger K; Reef SE
    MMWR Morb Mortal Wkly Rep; 2019 Oct; 68(39):855-859. PubMed ID: 31581161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Accelerated rubella and congenital rubella syndrome programme, Costa Rica.
    Wkly Epidemiol Rec; 2001 Aug; 76(35):265-70. PubMed ID: 11565150
    [No Abstract]   [Full Text] [Related]  

  • 30. Rubella in the United States: toward a strategy for disease control and elimination.
    Herrmann KL
    Epidemiol Infect; 1991 Aug; 107(1):55-61. PubMed ID: 1879490
    [No Abstract]   [Full Text] [Related]  

  • 31. Further efforts in the achievement of congenital rubella syndrome/rubella elimination.
    Cozza V; Martinelli D; Cappelli MG; Tafuri S; Fortunato F; Prato R
    Hum Vaccin Immunother; 2015; 11(1):220-4. PubMed ID: 25483539
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Strategies for elimination of rubella in pregnancy and of congenital rubella syndrome in high and upper-middle income countries.
    Terracciano E; Amadori F; Pettinicchio V; Zaratti L; Franco E
    J Prev Med Hyg; 2020 Mar; 61(1):E98-E108. PubMed ID: 32490275
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Balancing evidence and uncertainty when considering rubella vaccine introduction.
    Lessler J; Metcalf CJ
    PLoS One; 2013; 8(7):e67639. PubMed ID: 23861777
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modelling a Supplementary Vaccination Program of Rubella Using the 2012⁻2013 Epidemic Data in Japan.
    Kayano T; Lee H; Nishiura H
    Int J Environ Res Public Health; 2019 Apr; 16(8):. PubMed ID: 31027277
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progress toward elimination of rubella and congenital rubella syndrome--the Americas, 2003-2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Oct; 57(43):1176-9. PubMed ID: 18971920
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progress in Italy in control and elimination of measles and congenital rubella.
    Bonanni P; Bechini A; Boccalini S; Peruzzi M; Tiscione E; Boncompagni G; Mannelli F; Salmaso S; Filia A; Ciofi degli Atti M
    Vaccine; 2007 Apr; 25(16):3105-10. PubMed ID: 17306425
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety profile of rubella vaccine administered to pregnant women: A systematic review of pregnancy related adverse events following immunisation, including congenital rubella syndrome and congenital rubella infection in the foetus or infant.
    Mangtani P; Evans SJW; Lange B; Oberle D; Smith J; Drechsel-Baeuerle U; Keller-Stanislawski B
    Vaccine; 2020 Jan; 38(5):963-978. PubMed ID: 31839467
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of targeted wide age range SIAs in reducing measles incidence in the African Region.
    Masresha B; Luce R; Katsande R; Fall A; Eshetu M; Mihigo R
    Pan Afr Med J; 2017; 27(Suppl 3):13. PubMed ID: 29296148
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rubella and congenital rubella syndrome in the Americas.
    Arya SC; Agarwal N
    Rev Panam Salud Publica; 2004 Nov; 16(5):366-7. PubMed ID: 15729987
    [No Abstract]   [Full Text] [Related]  

  • 40. Elimination of rubella and congenital rubella syndrome in the Americas.
    Castillo-Solórzano C; Marsigli C; Bravo-Alcántara P; Flannery B; Ruiz Matus C; Tambini G; Gross-Galiano S; Andrus JK
    J Infect Dis; 2011 Sep; 204 Suppl 2():S571-8. PubMed ID: 21954249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.